These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28716462)

  • 1. Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum.
    Nimmo C; Doyle R; Burgess C; Williams R; Gorton R; McHugh TD; Brown M; Morris-Jones S; Booth H; Breuer J
    Int J Infect Dis; 2017 Sep; 62():44-46. PubMed ID: 28716462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.
    Doyle RM; Burgess C; Williams R; Gorton R; Booth H; Brown J; Bryant JM; Chan J; Creer D; Holdstock J; Kunst H; Lozewicz S; Platt G; Romero EY; Speight G; Tiberi S; Abubakar I; Lipman M; McHugh TD; Breuer J
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29848567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing.
    Soundararajan L; Kambli P; Priyadarshini S; Let B; Murugan S; Iravatham C; Tornheim JA; Rodrigues C; Gupta R; Ramprasad VL
    Tuberculosis (Edinb); 2020 Mar; 121():101915. PubMed ID: 32279871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic factors associated with acquired phenotypic drug resistance and its compensatory evolution during tuberculosis treatment.
    Zhang G; Sun X; Fleming J; Ran F; Luo J; Chen H; Ju H; Wang Z; Zhao H; Wang C; Zhang F; Dai X; Yang X; Li C; Liu Y; Wang Y; Zhang X; Jiang Y; Wu Z; Bi L; Zhang H
    Clin Microbiol Infect; 2024 May; 30(5):637-645. PubMed ID: 38286176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosis.
    Kambli P; Ajbani K; Kazi M; Sadani M; Naik S; Shetty A; Tornheim JA; Singh H; Rodrigues C
    Tuberculosis (Edinb); 2021 Mar; 127():102051. PubMed ID: 33450448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
    Somoskovi A; Dormandy J; Mitsani D; Rivenburg J; Salfinger M
    J Clin Microbiol; 2006 Dec; 44(12):4459-63. PubMed ID: 17035488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing.
    Gliddon HD; Frampton D; Munsamy V; Heaney J; Pataillot-Meakin T; Nastouli E; Pym AS; Steyn AJC; Pillay D; McKendry RA
    Microbiol Spectr; 2021 Dec; 9(3):e0061021. PubMed ID: 34817282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing.
    O'Donnell MR; Larsen MH; Brown TS; Jain P; Munsamy V; Wolf A; Uccellini L; Karim F; de Oliveira T; Mathema B; Jacobs WR; Pym A
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.
    Anthwal D; Gupta RK; Bhalla M; Bhatnagar S; Tyagi JS; Haldar S
    J Clin Microbiol; 2017 Jun; 55(6):1755-1766. PubMed ID: 28330890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.
    Lobie TA; Woldeamanuel Y; Asrat D; Beyene D; Bjørås M; Aseffa A
    PLoS One; 2020; 15(4):e0231320. PubMed ID: 32267877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparing performance of "TB-BIOCHIP", "Xpert MTB/RIF" and "genotype MTBDRplus" assays for fast identification of mutations in the Mycobacterium tuberculosis complex in sputum from TB patients].
    Nosova EIu; Krasnova MA; Galkina KIu; Makarova MV; Litvinov VI; Moroz AM
    Mol Biol (Mosk); 2013; 47(2):267-74. PubMed ID: 23808160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Second-Generation Line Probe Assay (Hain MTBDR
    Rockwood N; Wojno J; Ghebrekristos Y; Nicol MP; Meintjes G; Wilkinson RJ
    J Clin Microbiol; 2017 May; 55(5):1508-1515. PubMed ID: 28249999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
    Ogari CO; Nyamache AK; Nonoh J; Amukoye E
    BMC Infect Dis; 2019 Mar; 19(1):279. PubMed ID: 30909867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U
    Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A
    PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
    Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
    Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
    Wu X; Gao R; Shen X; Guo Y; Yang J; Wu Z; Tan G; Wang H; Yu F
    Int J Infect Dis; 2020 Jul; 96():48-53. PubMed ID: 32339720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.